UpdatesGeneral Updates
BETA has completed the acquisition of 66.09% equity in Nivian Lifesciences, acquiring 10,94,535 shares.
Beta Drugs LimitedBETA · Filed with the exchange
This makes Nivian a subsidiary.
BETA will now seek NSE listing approval for the share swap arrangements.
No comments yet. Be the first.